Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant <i>Klebsiella pneumoniae</i>: A Retrospective Case Series and Literature Review

Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant <i>Klebsiella pneumoniae</i>: A Retrospective Case Series and Literature Review

Objectives: The aim of this study was to describe our experience of a combination treatment including meropenem/vaborbactam (M/V) plus aztreonam (ATM) for bloodstream infections (BSIs) due to ceftazidime/avibactam-resistant <i>Klebsiella pneumoniae</i> (CAZ/AVI-R-<i>Kp</i>),...

Full description

Bibliographic Details
Main Authors: Alessandra Belati, Davide Fiore Bavaro, Lucia Diella, Nicolò De Gennaro, Francesco Di Gennaro, Annalisa Saracino
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Antibiotics
Subjects:
carbapenem-resistant Gram-negative
carbapenem-resistant <i>Klebsiella pneumoniae</i>
metallo-beta-lactamase carbapenemases
avibactam resistance
meropenem/vaborbactam
aztreonam
Online Access:https://www.mdpi.com/2079-6382/11/3/373

Internet

https://www.mdpi.com/2079-6382/11/3/373

Similar Items